曲唑酮治疗失眠及其相关抑郁、焦虑的专家 共识
作者:
作者单位:

作者简介:

通讯作者:

基金项目:


Expert consensus on the treatment of depression and anxiety comorbid insomnia with trazodone
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    失眠是临床常见症状,多与抑郁和焦虑障碍等精神疾病同时或相继发生,且临床上常难 以界定两者之间的因果关系。鉴于失眠与抑郁、焦虑存在的交互作用,对抑郁、焦虑和失眠进行综合干 预和管理成为目前疾病治疗的新趋势。曲唑酮是一种具有镇静催眠作用的抗抑郁药,临床广泛用于失 眠及抑郁焦虑伴发或共病失眠的患者。为规范曲唑酮在失眠领域的应用,编写共识的专家组成员通过 复习曲唑酮相关文献,同时结合国内外指南的推荐,重新总结了药物的药代动力学数据、药理作用及相 关临床应用方法,并经过专家组的反复讨论达成共识,以期为广大临床医师合理使用该药提供参考。

    Abstract:

    Insomnia is a common clinical problem. It can be comorbid with other psychiatric disorders such as major depressive disorder( MDD) and anxiety disorder( AD), which leads to hard definition of causality between insomnia and MDD/AD. In view of the mutual relationship between insomnia and MDD/ AD, Comprehensive intervention of both insomnia and MDD/AD has become a new trend. Trazodone, an antidepressant with sedative and hypnotic effects, is widely used in management of insomnia, depression and anxiety. In order to standardize the clinical practice of trazodone in treatment of insomnia, the experts committee of comorbid insomnia reviewed recent evidence and recommendations of guildelines, summarized the pharmacokinetics data, pharmacological effects and clinical applications of trazodone. After repeated discussions by the committee, the consensus was finally completed, which can provide useful clinical suggestion to physicians.

    参考文献
    相似文献
    引证文献
引用本文

曲唑酮治疗失眠及其相关抑郁、焦虑共识专家组 执笔:王赞 李雁鹏.曲唑酮治疗失眠及其相关抑郁、焦虑的专家 共识[J].神经疾病与精神卫生,2019,19(1):
DOI :10.3969/j. issn.1009-6574.2019.01.022.

复制
文章指标
  • 点击次数:
  • 下载次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2019-03-20